In addition, the role of the placenta in mediating the effects of FA on GDM warrants further exploration, not only through its regulation of endocrine peptides known to regulate maternal glucose homeostasis (including leptin, estradiol, progesterone, etc.), but also via other placental non-endocrine functions which may contribute to metabolic adaptations in pregnancy. The gene discussed is LEP; the disease is gestational diabetes.